This document discusses tuning fork tests used to assess hearing. A tuning fork produces a constant pitch when struck and is used to test air and bone conduction. The Rinne test compares air and bone conduction, with Rinne positive indicating normal hearing and Rinne negative indicating conductive hearing loss. The Weber test assesses lateralization of sound to the better or worse hearing ear. Other tests discussed include Schwabach, ABC, Gelle's, Bing, and tests for malingering like Stenger's test. Tuning fork tests can help differentiate conductive from sensorineural hearing loss.
In this PPT u will know about Tuning Fork and its types.
u can also know the principle , purpose , procedure and implications of types of tuning fork test.
hope this will help you all.
u can suggest me for better
@ - anantarun27@gmail.com
In this PPT u will know about Tuning Fork and its types.
u can also know the principle , purpose , procedure and implications of types of tuning fork test.
hope this will help you all.
u can suggest me for better
@ - anantarun27@gmail.com
One can conduct an otoscopic examination at home with the help of an otoscope. Depending on the quality of the product, the otoscope price ranges between Rs. 10,000 and Rs. 20,000.
One can conduct an otoscopic examination at home with the help of an otoscope. Depending on the quality of the product, the otoscope price ranges between Rs. 10,000 and Rs. 20,000.
description of various audiological assessment tests at bedside and via instruments for measurement of degree of hearing loss and help in identifying cause for hearing loss and type of hearing loss.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
2. Tuning Fork
• Is a small metal instrument
consisting of a stem, two prongs
and a foot Piece, that produces a
constant pitch when either prong is
struck against a firm but resilient
surface.
• It is usually made of steel,
magnesium or aluminum that is
used to tune musical instruments by
musicians and now used by doctors
to assess hearing.
• It vibrates sinusoidally to generate a
pure tone
3. Tuning Fork Test
• Used to differentiate between conductive and
sensorineural hearing loss.
• Test is performed with different types of frequency
like 128,256,512, 1024,2048 Hz. Routine practices
256Hz,512 Hz,1024Hz are used.
• Larger forks vibrate at slower frequency.
• Tuning fork is activated by striking against
examiner's elbow, heel of hand and placed 2cm
away from EAC for Air conduction and on mastoid
for Bone conduction.
4. Air Conduction (AC)
• Vibrating tuning fork is placed vertically in line with
the meatus about 2 cm away from the EAC
opening.
• The sound waves transmitted through TM –Middle
ear ossicles-Inner ear –Auditory Nerve –Auditory
Cortex.
• Both Conductive mechanism and Cochlea are
tested
5. Bone Conduction (BC)
• Foot plate of Vibrating tuning fork is placed on the
mastoid bone.
• Cochlea is stimulated directly by the vibrations
conducted through the Skull.
• BC measures only the cochlear functions.
• Normally AC will be more than BC
6.
7. Principles of Tuning Fork Tests
• Conductive Hearing loss (CHL)
o Sounds delivered to the ear via AC will be decreased
o If the sound is delivered to the ear via BC, bypassing
the OE & ME, then the sound will be heard normally
assuming there is no disorder.
• Sensory Hearing Loss (SNHL)
o Sounds delivered to the ear via BC will be deceased.
8. Types
• Rinne Test
• Weber Test
• ABC test
• Schwabach Test
• Gelle’s Test
• Bing Test
9. RINNE Test
• Proposed by Heinrich Adolf Rinne(1855)
• Air conduction is compared with bone
conduction
• The base of Vibrating tuning fork is placed firmly
over mastoid process,
• Patient is asked to indicate when sound disappears,
suddenly the tuning fork is placed vertically 2cm
from EAC,
• If hears still –AC more than BC.
• Rinne Positive.ie,Normal.
10.
11. Inference
• Rinne Positive
o Air Conduction >Bone Conduction=Normal or SNHL
• Rinne Negative
o Bone Conduction >Air Conduction =Conductive hearing
Loss
• False Negative Rinne
o Air conduction absent, but responds to bone conduction
o Response of bone conduction is due to transcranial
transmission from opposite ear
o Seen in UNILATERAL SENSORY HEARING LOSS.
12. Modified Rinne
• For routine purpose ,the patient is asked to
compare the sound intensities of tuning fork, while
placing in front of the ear and over the mastoid
process.
13. WEBER Test
• Proposed by Ernst Heinrich Weber.
• A test of lateralization
• A vibrating tuning fork is placed in the middle of
forehead or the vertex asked in which ear the
sound is heard.
• Normally, heard equally in both ears.
• Lateralized to the worst ear in conductive hearing
loss and better in Sensory neural loss ear.
• Sound travels directly to the cochlea through bone.
14. WEBER Test
• Based on “Stenger Principle”:
o If two tones are identical except they are
different in loudness, are introduced
simultaneously into both ears, only the louder
tone will be perceived
o Two ears, one has poorer BC sensitivity, when the
tone is being produced to both ears with equal
energy, the tone will be perceived softer or will
not be perceived at all in the poor ear.
15. Inference
• If the tone lateralizes to the poorer ear
• CHL in the poor ear
• If the tone lateralizes to the better/good ear:
• The cochlea with the best hearing sensitivity will detect the
signal
• SNHL in the poor ear
• If the sound is detected in the midline position:
• Normal hearing
• or equal amounts of the same type of HL in both ears (CHL,
SNHL)
16. SCHWABACH Test
• Once popular but no longer is in use.
• It compares pts. hearing sensitivity with that of an examiner
(assuming that he/she has a normal hearing).
• The fork is set into vibration, stem is placed alternately against
the mastoid process of the pt. and the examiner. Here meatus
is not closed.
• Vibratory energy of the tines of fork decreases overtime,
making the tone softer
• Pt. should indicate whether the tone is heard or not each time
• When the pt. no longer hears the tone, examiner immediately
places the stem behind his or her own ear and using a watch,
notes the number of seconds the tone is audible after the pt.
stops hearing it
17. Inference
• Normal Schwabach:
o Both pt. & examiner stop hearing the tone at
approximately the same time
• Pt. has normal BC
• Diminished Schwabach:
o Pt. stop hearing the sound much sooner than the examiner
• Pt. BC is impaired/SNHL
18. Absolute Bone Conduction(ABC)
• Modification of Schwabach test.
• Patients bone conduction is compared with that of
the examiner (assuming that he/she has a normal
hearing).
• EAC is occluded, by pressing the tragus inwards,to
prevent ambient noise entering through AC route.
• Inference
o Normal –Bone conduction of patient is equal to
examiner
o In SNHL ABC is reduced in comparison to examiner.
19. GELLE’s Test
• Test of bone conduction.
• Examines the effect of increased air pressure in ear
canal.
• Performed by vibrating fork on the mastoid
• By Increasing the pressure in the EAC with a Siegel's
speculum, it pushes the TM and ossicles inwards,
raises the intralabyrinthine pressure and causes
immobility of basilar membrane and decreased
hearing, but no change in hearing when ossicles
are fixed.
20. GELLE’s Test
• Inference
o Negative-When ossicular chain is fixed in case of
Otosclerosis or disconnected
o Positive –Normal case and SNHL
• This test is replaced with Tympanometry.
21. BING’s Test
• Proposed by Albert Bing
• It is test of Bone Conduction.
• Examines the effect of Occlusion of ear canal on
hearing.
• Vibrating tuning fork is placed on the mastoid while
examiner alternatively closes and open the ear
canal by pressing tragus inward.
• Inference
o Normal or SNHL hears louder when canal is occluded and
softer when the canal is open-BING POSITIVE
o CHL patients will appreciate no change.-BING NEGATIVE
22. Tuning Fork Tests For
Malingering
• Stenger’s test:
o This is based on “Stenger’s phenomenon”, when a listener is
presented with the same type of sound in both ears he will hear a
single sound, that too only in the ear which it is
louder. Procedure: Two tuning forks with frequency of 512 Hz are
kept equidistantly from both ears, one should be able to hear
equally well in either side. In malingering say i.e. left ear, even if
the tuning fork is moved too close to the left ear, the patient
denies that he is hearing in the right side also.
• Teal’s test:
o In this test a vibrating tuning fork is applied over the mastoid process
of the so called deaf ear, the patient accepts to hear it. Then the
patient is blind folded and with a non vibrating fork on the mastoid
process, the malingering patient claim’s to hear the sound.
23. • Chimani Mooss test:
o A variation of Weber’s test. Normally in Weber’s test the
patient hears the best in the occluded ear. In ,malingering
the patient will not accept to hear better in the occluded
ear.
Tuning Fork Tests For
Malingering